Trial Profile
A randomised double-blind placebo-controlled crossover trial to assess the effect of ZD4522 [rosuvastatin] on the incorporation of trideuterated leucine into lipid subfractions and apolipoproteins in subjects with mild to moderate hyperlipidaemia
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 27 Mar 2006
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 27 Mar 2006 New trial record.